LBA67 Phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients (Pts) with renal cell carcinoma (RCC) undergoing nephrectomy (PROSPER, ECOG-ACRIN EA8143), a National Clinical Trials Network trial.
Saved in:
| Title: | LBA67 Phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients (Pts) with renal cell carcinoma (RCC) undergoing nephrectomy (PROSPER, ECOG-ACRIN EA8143), a National Clinical Trials Network trial. |
|---|---|
| Authors: | Allaf, M.1 (AUTHOR), Kim, S.E.2 (AUTHOR), Harshman, L.C.3 (AUTHOR), McDermott, D.F.4 (AUTHOR), Master, V.A.5 (AUTHOR), Signoretti, S.6 (AUTHOR), Cole, S.7 (AUTHOR), Moon, H.8 (AUTHOR), Adra, N.9 (AUTHOR), Singer, E.A.10 (AUTHOR), Gills, J.11 (AUTHOR), Choueiri, T.K.12 (AUTHOR), Leibovich, B.13 (AUTHOR), Michaelson, M.D.14 (AUTHOR), B. shuch15 (AUTHOR), Lara, P.N.16 (AUTHOR), Heng, D.Y.C.17 (AUTHOR), Kapoor, A.18 (AUTHOR), Carducci, M.A.19 (AUTHOR), Haas, N.B.20 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1432-S1433. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.08.072 |
